| |
|
|
|
|
|
|
|||
|
Blood, 1 July 2006, Vol. 108, No. 1, pp. 141-151. Prepublished online as a Blood First Edition Paper on March 16, 2006; DOI 10.1182/blood-2005-04-1697.
Submitted April 26, 2005
Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, NY, USA * Corresponding author; email: feuerg{at}upstate.edu.
The cellular reservoir for KSHV infection in the hematopoietic compartment and mechanisms governing latent infection and reactivation remain undefined. To determine susceptibility of human CD34+ hematopoietic progenitor cells (HPCs) to infection with KSHV, purified HPCs were exposed to KSHV and cells were differentiated in vitro and in vivo. Clonogenic colony forming activity was significantly suppressed in KSHV-infected CD34+ cells and viral DNA was predominantly localized to granulocyte-macrophage colonies (CFU-GM) differentiated in vitro. rKSHV.219 is a recombinant KSHV construct which expresses GFP from a cellular promoter active during latency and RFP from a viral lytic promoter. Infection of CD34+ HPCs with rKSHV.219 showed similar patterns of infection, persistence and hematopoietic suppression in vitro in comparison with KSHV. rKSHV.219 infection was detected in human CD14+ and CD19+ cells recovered from NOD/SCID mouse bone marrow and spleen following reconstitution with rKSHV.219-infected CD34+ HPCs. These results suggest that rKSHV.219 establishes persistent infection in NOD/SCID mice and that virus may be disseminated following differentiation of infected HPCs into the B cell and monocyte lineages. CD34+ HPCs may be a reservoir for KSHV infection and may provide a continuous source of virally infected cells in vivo.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||